Charles Schwab’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.5M Buy
617,000
+46,850
+8% +$873K ﹤0.01% 1946
2025
Q1
$10.9M Sell
570,150
-32,171
-5% -$616K ﹤0.01% 1909
2024
Q4
$21.7M Buy
602,321
+16,258
+3% +$586K ﹤0.01% 1657
2024
Q3
$24.9M Buy
586,063
+18,874
+3% +$800K ﹤0.01% 1576
2024
Q2
$22.9M Buy
567,189
+149,646
+36% +$6.03M ﹤0.01% 1588
2024
Q1
$14.8M Buy
417,543
+20,802
+5% +$737K ﹤0.01% 1782
2023
Q4
$11.7M Buy
396,741
+29,730
+8% +$879K ﹤0.01% 1901
2023
Q3
$7.62M Buy
367,011
+16,586
+5% +$344K ﹤0.01% 2058
2023
Q2
$8.6M Buy
350,425
+1,978
+0.6% +$48.5K ﹤0.01% 1977
2023
Q1
$14.2M Buy
348,447
+5,921
+2% +$240K ﹤0.01% 1705
2022
Q4
$15.4M Buy
342,526
+8,562
+3% +$385K 0.01% 1608
2022
Q3
$16M Sell
333,964
-169,850
-34% -$8.13M 0.01% 1538
2022
Q2
$29.8M Buy
503,814
+234
+0% +$13.9K 0.01% 1100
2022
Q1
$58.6M Buy
503,580
+12,318
+3% +$1.43M 0.02% 770
2021
Q4
$73.9M Buy
491,262
+13,799
+3% +$2.08M 0.02% 677
2021
Q3
$57M Buy
477,463
+13,373
+3% +$1.6M 0.02% 782
2021
Q2
$45.2M Buy
464,090
+11,009
+2% +$1.07M 0.02% 945
2021
Q1
$40M Buy
453,081
+12,238
+3% +$1.08M 0.01% 978
2020
Q4
$42.2M Buy
440,843
+15,453
+4% +$1.48M 0.02% 873
2020
Q3
$48.3M Buy
425,390
+129,682
+44% +$14.7M 0.02% 680
2020
Q2
$29.3M Sell
295,708
-102,666
-26% -$10.2M 0.01% 915
2020
Q1
$25.6M Buy
398,374
+4,416
+1% +$284K 0.02% 842
2019
Q4
$23.5M Buy
393,958
+7,919
+2% +$472K 0.01% 1094
2019
Q3
$22.8M Buy
386,039
+51,676
+15% +$3.05M 0.01% 1050
2019
Q2
$21.6M Buy
334,363
+18,841
+6% +$1.22M 0.01% 1082
2019
Q1
$20M Buy
315,522
+14,933
+5% +$948K 0.01% 1106
2018
Q4
$11.4M Sell
300,589
-1,137
-0.4% -$43.2K 0.01% 1365
2018
Q3
$12.9M Buy
301,726
+206,040
+215% +$8.83M 0.01% 1464
2018
Q2
$2.11M Buy
+95,686
New +$2.11M ﹤0.01% 2360
2017
Q2
Sell
-3,539
Closed -$43K 3135
2017
Q1
$43K Sell
3,539
-2,138
-38% -$26K ﹤0.01% 3043
2016
Q4
$123K Buy
5,677
+324
+6% +$7.02K ﹤0.01% 3027
2016
Q3
$411K Buy
5,353
+273
+5% +$21K ﹤0.01% 2685
2016
Q2
$384K Buy
5,080
+84
+2% +$6.35K ﹤0.01% 2689
2016
Q1
$436K Buy
4,996
+102
+2% +$8.9K ﹤0.01% 2630
2015
Q4
$578K Buy
4,894
+130
+3% +$15.4K ﹤0.01% 2589
2015
Q3
$420K Buy
4,764
+1,552
+48% +$137K ﹤0.01% 2688
2015
Q2
$349K Buy
3,212
+147
+5% +$16K ﹤0.01% 2810
2015
Q1
$387K Buy
3,065
+209
+7% +$26.4K ﹤0.01% 2732
2014
Q4
$363K Buy
2,856
+824
+41% +$105K ﹤0.01% 2763
2014
Q3
$273K Buy
2,032
+40
+2% +$5.37K ﹤0.01% 2840
2014
Q2
$324K Sell
1,992
-13
-0.6% -$2.11K ﹤0.01% 2824
2014
Q1
$443K Buy
2,005
+48
+2% +$10.6K ﹤0.01% 2631
2013
Q4
$505K Buy
+1,957
New +$505K ﹤0.01% 2583